§ BIOTECHNOLOGY
USD · Biotechnology

MIRM

MIRUM PHARMACEUTICALS INC
USDSector · BiotechnologyBeta · 0.54
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
197 increased/new, 105 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B12.97EPS (TTM)-0.48
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Frazier Life Sciences Management, L.P.7.7M18.3%+13%
JANUS HENDERSON GROUP PLC6.9Mn/a+15%
BlackRock, Inc.3.8M0.0%+6%
VANGUARD CAPITAL MANAGEMENT LLC2.4Mn/an/a
Fidelity Management2.0M0.0%+204%
State Street1.9M0.0%−9%
◇ AC INTELLIGENCE

Top institutional owners for MIRM as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER98.7% · 0 holders
OTHER0.7% · 222 holders
QUALITY / COMPOUNDER0.4% · 26 holders
DEALER / BANK0.1% · 28 holders
PASSIVE / INDEX0.1% · 9 holders
TACTICAL / MACRO0.0% · 4 holders
SYSTEMATIC / QUANT0.0% · 8 holders
INCOME / DEFENSIVE0.0% · 14 holders
ACTIVIST0.0% · 1 holder
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for MIRM in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention MIRM yet.